MBX Biosciences (MBX) Depreciation and Depletion (2023 - 2026)
MBX Biosciences has reported Depreciation and Depletion over the past 4 years, most recently at $64000.0 for Q1 2026.
- Quarterly results put Depreciation and Depletion at $64000.0 for Q1 2026, down 16.88% from a year ago — trailing twelve months through Mar 2026 was $312000.0 (down 2.8% YoY), and the annual figure for FY2025 was $248000.0, up 1.64%.
- Depreciation and Depletion reached $64000.0 in Q1 2026 per MBX's latest filing, up from $48000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $100000.0 in Q3 2023 and bottomed at $41000.0 in Q4 2023.
- Median Depreciation and Depletion over the past 4 years was $77000.0 (2025), compared with a mean of $74727.3.
- The largest annual shift saw Depreciation and Depletion surged 60.42% in 2025 before it fell 16.88% in 2026.
- Over 4 years, Depreciation and Depletion stood at $41000.0 in 2023, then rose by 7.32% to $44000.0 in 2024, then rose by 9.09% to $48000.0 in 2025, then surged by 33.33% to $64000.0 in 2026.
- Business Quant data shows Depreciation and Depletion for MBX at $64000.0 in Q1 2026, $48000.0 in Q4 2025, and $100000.0 in Q3 2025.